Cargando…
A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome
BACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness, characterised by persistent fatigue that is unrelieved by rest, in combination with a range of other disabling symptoms. There is no diagnostic test nor targeted treatment available for this illness. T...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890871/ https://www.ncbi.nlm.nih.gov/pubmed/33596913 http://dx.doi.org/10.1186/s12967-021-02742-4 |
_version_ | 1783652585773727744 |
---|---|
author | Maksoud, Rebekah Balinas, Cassandra Holden, Sean Cabanas, Hélène Staines, Donald Marshall-Gradisnik, Sonya |
author_facet | Maksoud, Rebekah Balinas, Cassandra Holden, Sean Cabanas, Hélène Staines, Donald Marshall-Gradisnik, Sonya |
author_sort | Maksoud, Rebekah |
collection | PubMed |
description | BACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness, characterised by persistent fatigue that is unrelieved by rest, in combination with a range of other disabling symptoms. There is no diagnostic test nor targeted treatment available for this illness. The pathomechanism also remains unclear. Mitochondrial dysfunctions have been considered a possible underlying pathology based on reported differences including structural and functional changes in ME/CFS patients compared to healthy controls. Due to the potential role that mitochondria may play in ME/CFS, mitochondrial-targeting nutraceutical interventions have been used to potentially assist in improving patient outcomes such as fatigue. The aim of this systematic review is to appraise literature assessing these nutraceuticals as a possible intervention for treating ME/CFS. METHODS: A systematic search of Pubmed, Embase, Medline (EBSCO host) and Web of Science (via Clarivate Analytics) for journal articles published between January 1995 and 10th November 2020 was conducted. Articles assessing nutraceutical interventions and ME/CFS patient outcomes were retrieved. Using specific inclusion and exclusion criteria, the list of articles was further refined. Quality was measured using the Rosendal scale. RESULTS: Nine intervention studies were included in this review. The studies investigated patient symptom severity changes such as altered fatigue levels in response to mitochondrial-targeting nutraceuticals. Improvements in fatigue levels were observed in six of the nine studies. Secondary outcomes assessed include biochemical, psychological, and quality of life parameters. CONCLUSION: There is insufficient evidence on the effectiveness of mitochondria- targeting nutraceuticals in ME/CFS patients. Future well-designed studies are required to elucidate both the involvement of mitochondria in the pathomechanism of ME/CFS and the effect of mitochondrial-modifying agents on illness severity. |
format | Online Article Text |
id | pubmed-7890871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78908712021-02-22 A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome Maksoud, Rebekah Balinas, Cassandra Holden, Sean Cabanas, Hélène Staines, Donald Marshall-Gradisnik, Sonya J Transl Med Review BACKGROUND: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating illness, characterised by persistent fatigue that is unrelieved by rest, in combination with a range of other disabling symptoms. There is no diagnostic test nor targeted treatment available for this illness. The pathomechanism also remains unclear. Mitochondrial dysfunctions have been considered a possible underlying pathology based on reported differences including structural and functional changes in ME/CFS patients compared to healthy controls. Due to the potential role that mitochondria may play in ME/CFS, mitochondrial-targeting nutraceutical interventions have been used to potentially assist in improving patient outcomes such as fatigue. The aim of this systematic review is to appraise literature assessing these nutraceuticals as a possible intervention for treating ME/CFS. METHODS: A systematic search of Pubmed, Embase, Medline (EBSCO host) and Web of Science (via Clarivate Analytics) for journal articles published between January 1995 and 10th November 2020 was conducted. Articles assessing nutraceutical interventions and ME/CFS patient outcomes were retrieved. Using specific inclusion and exclusion criteria, the list of articles was further refined. Quality was measured using the Rosendal scale. RESULTS: Nine intervention studies were included in this review. The studies investigated patient symptom severity changes such as altered fatigue levels in response to mitochondrial-targeting nutraceuticals. Improvements in fatigue levels were observed in six of the nine studies. Secondary outcomes assessed include biochemical, psychological, and quality of life parameters. CONCLUSION: There is insufficient evidence on the effectiveness of mitochondria- targeting nutraceuticals in ME/CFS patients. Future well-designed studies are required to elucidate both the involvement of mitochondria in the pathomechanism of ME/CFS and the effect of mitochondrial-modifying agents on illness severity. BioMed Central 2021-02-17 /pmc/articles/PMC7890871/ /pubmed/33596913 http://dx.doi.org/10.1186/s12967-021-02742-4 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Maksoud, Rebekah Balinas, Cassandra Holden, Sean Cabanas, Hélène Staines, Donald Marshall-Gradisnik, Sonya A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
title | A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
title_full | A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
title_fullStr | A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
title_full_unstemmed | A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
title_short | A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
title_sort | systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890871/ https://www.ncbi.nlm.nih.gov/pubmed/33596913 http://dx.doi.org/10.1186/s12967-021-02742-4 |
work_keys_str_mv | AT maksoudrebekah asystematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT balinascassandra asystematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT holdensean asystematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT cabanashelene asystematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT stainesdonald asystematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT marshallgradisniksonya asystematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT maksoudrebekah systematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT balinascassandra systematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT holdensean systematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT cabanashelene systematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT stainesdonald systematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome AT marshallgradisniksonya systematicreviewofnutraceuticalinterventionsformitochondrialdysfunctionsinmyalgicencephalomyelitischronicfatiguesyndrome |